Robert J. Kiernan - Mar 4, 2022 Form 4 Insider Report for Global Medical REIT Inc. (GMRE)

Role
Chief Financial Officer
Signature
/s/ Jamie Barber, as Attorney-in-Fact
Stock symbol
GMRE
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 06:08 PM
Previous filing
Mar 1, 2022
Next filing
Feb 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMRE LTIP Unit (Right to Buy) Award $0 +19.3K +7.49% $0.00 276K Mar 4, 2022 Common Stock 19.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.
F2 As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Remarks:

Exhibit List: Exhibit 24: Power of Attorney